to discover possible genetic determinants of human developmental disorders. Characterising the changes in mouse embryos that result from ablation of lethal genes is a necessary first step towards uncovering their role in normal embryonic development and establishing any correlates amongst human congenital abnormalities. Here we present results gathered to date in the Deciphering the Mechanisms of Developmental Disorders (DMDD) programme, cataloguing the morphological defects identified from comprehensive imaging of 220 homozygous mutant embryos from 42 lethal and subviable lines, analysed at E14.5.
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Virtually all embryos show multiple abnormal phenotypes and amongst the 42 lines these affect most organ systems. Within each mutant line, the phenotypes of individual embryos form distinct but overlapping sets. Subcutaneous edema, malformations of the heart or great vessels, abnormalities in forebrain morphology and the musculature of the eyes are all prevalent phenotypes, as is loss or abnormal size of the hypoglossal nerve. The most striking finding is that no matter how profound the malformation, each phenotype shows highly variable penetrance within a mutant line. These findings have challenging implications for efforts to identify human disease correlates. Gorlin syndrome is a rare autosomal dominant disorder, characterized by developmental abnormalities and predisposition to malignant cancers, including basal cell carcinoma, medulloblastoma, and rhabdomyosarcoma, as well as benign tumors, such as keratocystic odontogenic tumors (KCOTs) and ovarian and cardiac fibromas. The Hedgehog receptor PTCH1 has been designated to be responsible for Gorlin syndrome. Among these tumors, KCOTs are exhibited by more than 80% of patients with Gorlin syndrome from a very early age. PTCH1 mutations have also been reported in patients with the sporadic type of KCOTs. KCOTs are benign neoplasms of odontogenic origin, with a lining characterized as the parakeratinized squamous epithelium. Compare with studies on other tumors, those on KCOTs have been delayed because of the lack of a proper in vitro system. We established two KCOT cell lines, one each from a patient with Gorlin syndrome and a patient with sporadic tumor, to understand the nature and origin of KCOTs. The Gorlin syndrome-derived KCOT cell line iKCOT1 retained a germlinemutated PTCH1 allele and a wild-type PTCH1 allele. The sporadic KCOT-derived KCOT cell line sKCOT1 had different loss-of-function PTCH1 mutations on both alleles. Both cell lines expressed stem cell markers (CD44, SOX2, and BMI1), mesenchymal cell markers (CDH2, VIM, and SNAI2), and a neurogenic marker (NEFL). Culturing the cells in media with high calcium concentration induced the expression of epithelial cell and keratinocyte marker proteins (CDH1, CLDN1, IVL, and KRT10) and reciprocally reduced mesenchymal cell marker proteins. Under the high calcium condition, parakeratosis, which is characteristic of KCOTs, was observed in normal and three-dimensional cultures. The similarities in protein expression patterns and RNA-seq results between the two cell lines indicated that common mechanisms underlie the development of both types of KCOTs and the presence of a probable common origin of KCOT cells. Although some vessel-like structures are formed in vitro, they are not perfusable due to their blind-ends. To make vessel-like structures perfusable, we previously presented a microfluidic device to connect a vessel-like structure with microchannels (EMBO organoid symposium 2016). In this study, we report a tumor spheroid culture in perfusion condition to mimic tumor microenvironment.
We used a tri-culture spheroid as a tumor model which comprised of human lung fibroblasts (hLFs), human umbilical vein endothelial cells (HUVECs) and human breast cancer cells (MCF-7). A microfluidic device consisted of three channels separated by microposts (Kim et al., Lab Chip 2013) . A central channel was used for cultivation of a spheroid in fibrin-collagen gel. HUVECs were introduced to fibrin gel-medium interfaces to facilitate connections between vasculature and microchannel. The cells were incubated in a static condition to connect the vessel-like structures in the spheroid with microchannels. After 7 days in static culture, microchannels were connected with a syringe pump and perfusion culture were observed for 5 days.
By secretions from LFs in a spheroid, angiogenic sprouts were formed and migrated toward the tumor spheroid. After 2 days in static culture, angiogenic sprouts from both ends reached the spheroid and finally formed a perfusable vasculature on day 7. Next, we investigated a perfusion culture using a constructed vasculature. During the perfusion culture, we observed vascular remodeling, such as vascular dilation, which could not be observed in the static condition. The spheroid condition is under investigation. These results suggested that our vasculatures are applicable to perfusion culture and the vascular patterns can be flexibly remodeled by environmental stimuli, which is suitable for various tissue culture including a tumor. 
